Literature DB >> 12124710

Photoeradication of Helicobacter pylori using 5-aminolevulinic acid: preliminary human studies.

Clive H Wilder-Smith1, Petra Wilder-Smith, Pierre Grosjean, Hubert van den Bergh, Alain Woodtli, Philippe Monnier, Gian Dorta, Friedrich Meister, Georges Wagnières.   

Abstract

BACKGROUND AND OBJECTIVES: Helicobacter pylori (HP) is an endemic pathogenic bacterium causing gastritis and gastroduodenal ulceration in humans and is linked to the development of gastric malignancies. These first human in vivo studies investigated the photoeradication of HP using laser and white light. STUDY DESIGN/
MATERIALS AND METHODS: In 13 HP-positive volunteers, a zone of gastric antrum was irradiated with laser (410 nm, 50 J/cm(2)) or endoscopic white light (10 J/cm(2)) 45 minutes after oral 5-aminolevulinic acid (5-ALA) 20 mg/kg. HP-eradication was assessed by biopsy urease test and HP-culture from irradiated and control zones 5 minutes, 4 and 48 hours post-irradiation.
RESULTS: A maximum eradication effect was achieved at 4 hours post-irradiation when 85% of biopsies in the monochromatic and 66% in the white light exposed zones, and 58 and 33% in the respective control zones were HP-negative.
CONCLUSIONS: HP numbers were greatly reduced following exposure to 5-ALA and either laser or white light in vivo. Photoeradication appears feasible, but further light dosimetry and the development of convenient application methods is required. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12124710     DOI: 10.1002/lsm.10066

Source DB:  PubMed          Journal:  Lasers Surg Med        ISSN: 0196-8092            Impact factor:   4.025


  13 in total

1.  Photodynamic therapy: a new antimicrobial approach to infectious disease?

Authors:  Michael R Hamblin; Tayyaba Hasan
Journal:  Photochem Photobiol Sci       Date:  2004-02-12       Impact factor: 3.982

Review 2.  Photodynamic therapy targeted to pathogens.

Authors:  T N Demidova; M R Hamblin
Journal:  Int J Immunopathol Pharmacol       Date:  2004 Sep-Dec       Impact factor: 3.219

Review 3.  Photodynamic therapy for infections: clinical applications.

Authors:  Gitika B Kharkwal; Sulbha K Sharma; Ying-Ying Huang; Tianhong Dai; Michael R Hamblin
Journal:  Lasers Surg Med       Date:  2011-09       Impact factor: 4.025

4.  Helicobacter pylori in patients can be killed by visible light.

Authors:  Robert A Ganz; Jennifer Viveiros; Aamir Ahmad; Atosa Ahmadi; Ayesha Khalil; M Joshua Tolkoff; Norman S Nishioka; Michael R Hamblin
Journal:  Lasers Surg Med       Date:  2005-04       Impact factor: 4.025

Review 5.  All you need is light: antimicrobial photoinactivation as an evolving and emerging discovery strategy against infectious disease.

Authors:  Tyler G St Denis; Tianhong Dai; Leonid Izikson; Christos Astrakas; Richard Rox Anderson; Michael R Hamblin; George P Tegos
Journal:  Virulence       Date:  2011-11-01       Impact factor: 5.882

6.  Helicobacter pylori accumulates photoactive porphyrins and is killed by visible light.

Authors:  Michael R Hamblin; Jennifer Viveiros; Changming Yang; Atosa Ahmadi; Robert A Ganz; M Joshua Tolkoff
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

Review 7.  Photodynamic therapy for localized infections--state of the art.

Authors:  Tianhong Dai; Ying-Ying Huang; Michael R Hamblin
Journal:  Photodiagnosis Photodyn Ther       Date:  2009 Sep-Dec       Impact factor: 3.631

8.  Optical monitoring and treatment of potentially lethal wound infections in vivo.

Authors:  Michael R Hamblin; Touqir Zahra; Christopher H Contag; Albert T McManus; Tayyaba Hasan
Journal:  J Infect Dis       Date:  2003-05-15       Impact factor: 5.226

Review 9.  Light based anti-infectives: ultraviolet C irradiation, photodynamic therapy, blue light, and beyond.

Authors:  Rui Yin; Tianhong Dai; Pinar Avci; Ana Elisa Serafim Jorge; Wanessa C M A de Melo; Daniela Vecchio; Ying-Ying Huang; Asheesh Gupta; Michael R Hamblin
Journal:  Curr Opin Pharmacol       Date:  2013-09-20       Impact factor: 5.547

10.  Effects on gram-negative and gram-positive bacteria mediated by 5-aminolevulinic Acid and 5-aminolevulinic acid derivatives.

Authors:  Nicolas Fotinos; Maruska Convert; Jean-Claude Piffaretti; Robert Gurny; Norbert Lange
Journal:  Antimicrob Agents Chemother       Date:  2008-01-14       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.